Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration - PubMed (original) (raw)
Comparative Study
doi: 10.1002/jnr.20870.
Affiliations
- PMID: 16634056
- DOI: 10.1002/jnr.20870
Free article
Comparative Study
Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration
Pedro Garção et al. J Neurosci Res. 2006 Jul.
Free article
Abstract
The inflammatory responses in Alzheimer's disease (AD) and prion-related encephalopathies (PRE) are dominated by microglia activation. Several studies have reported that the amyloid-beta (Abeta) peptides, which are associated with AD, and the pathogenic isoform of prion protein (PrPSc) have a crucial role in neuronal death and gliosis that occur in both of these disorders. In this study, we investigate whether Abeta and PrPSc cause microglia activation per se and whether these amyloidogenic peptides differentially affect these immunoeffector cells. In addition, we also determined whether substances released by Abeta- and PrP-activated microglia induce neuronal death. Cultures of rat brain microglia cells were treated with the synthetic peptides Abeta1-40, Abeta1-42 and PrP106-126 for different time periods. The lipopolysaccharide was used as a positive control of microglia activation. Our results show that Abeta1-40 and PrP106-126 caused similar morphological changes in microglia and increased the production of nitric oxide and hydroperoxides. An increase on inducible nitric oxide synthase expression was also observed in microglia treated with Abeta1-40 or PrP106. However, these peptides affected in a different manner the secretion of interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) secretion. In cocultures of microglia-neurons, it was observed that microglia treated with Abeta1-40 or PrP106-126 induced a comparable extent of neuronal death. The neutralizing antibody for IL-6 significantly reduced the neuronal death induced by Abeta- or PrP-activated microglia. Taken together, the data indicate that Abeta and PrP peptides caused microglia activation and differentially affected cytokine secretion. The IL-6 released by reactive microglia caused neuronal injury.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
- Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR, Guirguis R, Brazier MW, Jobling MF, Hill AF, Beyreuther K, Barrow CJ, Masters CL, Collins SJ, Cappai R. White AR, et al. Neurobiol Dis. 2001 Apr;8(2):299-316. doi: 10.1006/nbdi.2001.0386. Neurobiol Dis. 2001. PMID: 11300725 - Detoxified lipopolysaccharide reduces microglial cell killing of prion-infected neurons.
Bate C, Williams A. Bate C, et al. Neuroreport. 2004 Dec 22;15(18):2765-8. Neuroreport. 2004. PMID: 15597050 - Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures.
Lotz M, Ebert S, Esselmann H, Iliev AI, Prinz M, Wiazewicz N, Wiltfang J, Gerber J, Nau R. Lotz M, et al. J Neurochem. 2005 Jul;94(2):289-98. doi: 10.1111/j.1471-4159.2005.03188.x. J Neurochem. 2005. PMID: 15998280 - The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
Chiarini A, Dal Pra I, Whitfield JF, Armato U. Chiarini A, et al. Ital J Anat Embryol. 2006 Oct-Dec;111(4):221-46. Ital J Anat Embryol. 2006. PMID: 17385278 Review. - Microglia and prion disease.
Brown DR. Brown DR. Microsc Res Tech. 2001 Jul 15;54(2):71-80. doi: 10.1002/jemt.1122. Microsc Res Tech. 2001. PMID: 11455614 Review.
Cited by
- Toll-like receptor 2 deficiency shifts PrP106-126-induced microglial activation from a neurotoxic to a neuroprotective phenotype.
Wang J, Zhao D, Pan B, Fu Y, Shi F, Kouadir M, Yang L, Yin X, Zhou X. Wang J, et al. J Mol Neurosci. 2015 Apr;55(4):880-90. doi: 10.1007/s12031-014-0442-0. Epub 2014 Oct 21. J Mol Neurosci. 2015. PMID: 25330861 - Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease.
Hay AJD, Latham AS, Mumford G, Hines AD, Risen S, Gordon E, Siebenaler C, Gilberto VS, Zabel MD, Moreno JA. Hay AJD, et al. Front Neurosci. 2023 May 12;17:1158408. doi: 10.3389/fnins.2023.1158408. eCollection 2023. Front Neurosci. 2023. PMID: 37250395 Free PMC article. - Adipose-derived mesenchymal stromal cells decrease prion-induced glial inflammation in vitro.
Hay AJD, Murphy TJ, Popichak KA, Zabel MD, Moreno JA. Hay AJD, et al. Sci Rep. 2022 Dec 29;12(1):22567. doi: 10.1038/s41598-022-26628-7. Sci Rep. 2022. PMID: 36581683 Free PMC article. - Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia.
Hjorth E, Frenkel D, Weiner H, Schultzberg M. Hjorth E, et al. Int J Alzheimers Dis. 2010 May 20;2010:798424. doi: 10.4061/2010/798424. Int J Alzheimers Dis. 2010. PMID: 20798889 Free PMC article. - Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions.
Tu J, Chen B, Yang L, Qi K, Lu J, Zhao D. Tu J, et al. J Mol Neurosci. 2015 Jun;56(2):509-18. doi: 10.1007/s12031-015-0553-2. Epub 2015 Apr 14. J Mol Neurosci. 2015. PMID: 25869610
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials